Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium - 27/09/17
, Richard L. Clark, BS b, Peter R. Kowey, MD c, Suneet Mittal, MD d, Preston Dunnmon, MD e, Norman Stockbridge, MD e, James A. Reiffel, MD f, Mintu P. Turakhia, MD, MAS g, Paul D. Ziegler, MS b, Robert B. Kleiman, MD h, Fraz Ismat, MD i, Philip Sager, MD jAbstract |
This white paper, prepared by members of the Cardiac Safety Research Consortium (CSRC), discusses important issues regarding scientific and clinical aspects of long-term electrocardiographic safety monitoring during clinical drug development. To promote multistakeholder discussion of this topic, a Cardiac Safety Research Consortium–sponsored Think Tank was held on 2 December 2015 at the American College of Cardiology's Heart House in Washington, DC. The goal of the Think Tank was to explore how and under what circumstances new and evolving ambulatory monitoring technologies could be used to improve and streamline drug development. This paper provides a detailed summary of discussions at the Think Tank: it does not represent regulatory guidance.
Le texte complet de cet article est disponible en PDF.Plan
| Disclaimer The opinions and conclusions expressed in this article are solely the views of the authors and do not necessarily represent views of the United States Food and Drug Administration or other author affiliations. |
Vol 187
P. 156-169 - mai 2017 Retour au numéro
Article précédent
- Managing subfertility in patients with heart disease: What are the choices?
- Matthew Cauldwell, Roshni R. Patel, Philip J. Steer, Lorna Swan, Julian Norman-Taylor, Michael Gatzoulis, Mark R. Johnson
- Assessing MICRO-vascular resistances via IMR to predict outcome in STEMI patients with multivessel disease undergoing primary PCI (AMICRO): Rationale and design of a prospective multicenter clinical trial
- Massimo Fineschi, Edoardo Verna, Giuseppe Mezzapelle, Davide Bartolini, Giovanni Turiano, Antonio Manari, Katia Lucarelli, Lucia Uguccioni, Alessandra Repetto, Giuseppe Tarantini
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?